Cyber Resilience

CVE-2024-10197

MediumPublic PoC

Published: 21 October 2024

Published
21 October 2024
Modified
23 October 2024
KEV Added
Patch
CVSS Score v4 5.1 CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
EPSS Score 0.0014 33.9th percentile
Risk Priority 10 60% EPSS · 20% KEV · 20% CVSS

Summary

CVE-2024-10197 is a medium-severity Cross-site Scripting (CWE-79) vulnerability in Code-Projects Pharmacy Management System. Its CVSS base score is 5.1 (Medium).

Operationally, ranked at the 33.9th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog; a public proof-of-concept is referenced.

EU & UK References

Vulnerability details

A vulnerability was found in code-projects Pharmacy Management System 1.0. It has been classified as problematic. Affected is an unknown function of the file /manage_supplier.php of the component Manage Supplier Page. The manipulation of the argument address leads to cross…

more

site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. Other parameters might be affected as well.

CWE(s)

Related Threats

No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.

Affected Assets

code-projects
pharmacy management system
1.0

Mitigating Controls

Likely Mitigating Controls AI

Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.

addresses: CWE-79

Penetration testing submits XSS payloads to web applications, detecting cross-site scripting flaws for subsequent remediation.

addresses: CWE-79

Validates web inputs to reject script-related content that could produce XSS.

addresses: CWE-79

Output validation against expected content can reject or sanitize script content in generated web pages, reducing XSS exploitability.

References